2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
D

2020 ASCO Update on Hodgkin Lymphoma: Pembro vs. Brentuximab Vedotin in Late Stage Disease - Which Option is Superior?

By 2020 ASCO Virtual Direct™ Highlights FEATURING David Maloney
By 2020 ASCO Virtual Direct™ Highlights FEATURING David Maloney
150 views
August 19, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Hematologic Oncology
09:23

2020 ASCO Update on Hodgkin Lymphoma: Pembro vs. Brentuximab Vedotin…

2020 ASCO Virtual Direct™ Highlights

D. Maloney

150 views
08:34

2020 ASCO Update on Waldenström Macroglobulinemia: Zanubrutinib vs. …

2020 ASCO Virtual Direct™ Highlights

D. Maloney

339 views
07:09

2020 ASCO Update on DLBCL: Venetoclax + Dose-Adjusted R-EPOCH - Did …

2020 ASCO Virtual Direct™ Highlights

D. Maloney

186 views
10:30

2020 ASCO Update on FL: Is CAR-T Axi-Cel Therapy a Promising Therape…

2020 ASCO Virtual Direct™ Highlights

D. Maloney

101 views